宫腹腔镜联合诊治输卵管性不孕症的价值

目的:探讨宫、腹腔镜联合诊治输卵管性不孕症的临床应用价值。方法:回顾分析2010年5月至2012年4月在我院住院行宫、腹腔镜联合诊治术的177例输卵管性不孕症患者的临床资料,并随访其术后妊娠情况。结果:患者术后的自然妊娠率为40.11%(71/177),其中70.42%发生于术后6个月内(50/71);异位妊娠率为3.39%(6/177)。患者的术后自然妊娠率与不孕时间呈显著负相关(β=-0.178,P0.05),而与年龄和不孕症类型无关。结论:宫、腹腔镜联合诊治术对输卵管性不孕症的诊断和治疗均具有临床应用价值,对术后1年未自然妊娠者应积极行辅助生殖技术治疗。不孕时间越长,术后自然妊娠的可能性越小。     

富腹腔镜联合治疗不孕症的临床研究

目的：通过对我院病例的研究,分析宫腹腔镜联合应用在治疗输卵管性不孕症中的作用。方法：选取我院2013年1月至2013年12月间的70例不孕症患者,并将其随机分为实验组和对照组两组,每组35例。实验组患者采用宫腹腔镜联合手术诊治,对照组行宫腔镜下导丝介入治疗。比较两种方法治疗后的自然妊娠率以及妊娠结果。结果：宫腹腔镜联合手术治疗后自然妊娠率以及异位妊娠几率均明显优于对照组,组间差异具有统计学意义（P〈0．05）。结论：宫腹腔镜联合手术诊治不孕症,疗效确切,自然妊娠率高、异位妊娠率低,具有明显的优势。     

宫、腹腔镜联合诊治输卵管性不孕症111例分析

目的:探讨宫、腹腔镜联合手术在输卵管性不孕症诊治中的临床价值。方法:应用宫、腹腔镜联合手术诊治111例输卵管性不孕患者,分析输卵管性不孕的主要原因和治疗效果。结果:111例中双侧输卵管阻塞35例(31.5%),单侧输卵管阻塞合并盆腔粘连18例(16.2%),双侧输卵管积水合并伞端闭锁58例(52.3%)。经治疗后50例双侧输卵管通畅(45.1%);39例一侧通畅(35.1%)。至今,共妊娠50例(45.1%)。结论:宫、腹腔镜联合手术是女性不孕症诊治的重要手段,治疗输卵管性不孕,特别是近端阻塞者再通率高、创伤小、疗效肯定,值得推广应用。     

子宫输卵管造影术和宫-腹腔镜联合手术在女性不孕症中的应用

目的:回顾性分析142例不孕症患者,子宫输卵管造影术和宫腹腔镜联合检查术在女性不孕症中的应用价值。方法:对先后行子宫输卵管造影术(HSG)和宫腹腔镜(Hsc-Lsc)联合手术的142例不孕症患者进行回顾性对比分析。结果:HSG与Hsc-Lsc联合应用对宫腔疾病的诊断符合率为85.21%,对输卵管疾病的诊断符合率为80.10%,对盆腔疾病的诊断符合率为54.23%。结论:子宫输卵管造影术、宫-腹腔镜联合手术是目前诊治女性不孕症较为有效的方法。     

宫腹腔镜联合手术在不孕症中的应用

目的：探讨宫、腹腔镜联合手术在不孕症诊疗中的应用价值。方法：回顾性分析2012年1月至2012年12月期间我院应用宫、腹腔镜联合手术治疗的53例女性不孕症患者的临床资料,不孕症的主要原因有：输卵管堵塞、盆腔粘连、多囊卵巢、子宫内膜异位症、子宫内膜息肉等。结果：所有53例患者均完成宫腔镜、腹腔镜治疗不孕症手术。手术后的妊娠率为47．16％。结论：宫腔镜、腹腔镜联合手术可以全面的评价、诊断以及治疗不孕不育症,是诊治女性不孕症的重要手段,再通率高、疗效肯定、创伤小,值得推广应用。     

宫腹腔镜联合手术和子宫输卵管碘油造影在输卵管性不孕中的应用价值

育龄妇女中各种原因所致的不孕症约占10％,其中输卵管性不孕的发病率较高,占不孕症病因的30％～40％。随着宫腔镜、腹腔镜的诊断和治疗技术在妇产科领域的应用和普及,宫腹腔镜联合手术为输卵管性不孕的治疗开辟了一条新途径。子宫输卵管碘油造影（hysterosalpinggography,HSG）广泛应用于不孕症检查中。本文旨在探讨宫腹腔镜联合检查与子宫输卵管碘油造影在诊断子宫输卵管性不孕中的一致性及宫腹腔镜联合在诊治子宫输卵管性不孕的价值。     

宫腹腔镜术联合中药五联疗法治疗输卵管不孕46例

目的:探讨宫腹腔镜手术后配合中药口服、中药保留灌肠、中药热敷、低频脉冲电治疗、针灸治疗输卵管阻塞性不孕的临床疗效。方法:将确诊为输卵管阻塞性不孕症的92例患者随机分为治疗组和对照组。两组均采取宫腹腔镜手术及术后输卵管插管通液治疗,治疗组术后加用中药口服、中药保留灌肠、中药热敷、低频脉冲电治疗、针灸五联疗法,对照组术后未使用五联疗法。随访其妊娠情况。结果:治疗组正常妊娠34例,占73.9%;对照组正常妊娠18例,占39.1%,经统计学分析有显著性差异(P<0.05)。结论:宫腹腔镜手术联合中药五联疗法是治疗输卵管阻塞性不孕的有效方法,值得临床推广应用。     

宫腹腔镜联合手术加用透明质酸钠防治输卵管疏通术后再阻塞效果分析

宫、腹腔镜联合手术是目前治疗输卵管阻塞性不孕的主要方法,但如何防止术后再粘连、再阻塞仍是临床需要解决的难点。我院在宫腹腔镜联合手术中加用透明质酸钠预防术后再粘连、再阻塞,取得满意效果,现报道如下。1资料与方法1.1一般资料2005年2月至2006年2月将我院因输卵管阻塞性不孕行输卵管疏通术的53例,分为两组:(1)宫、腹腔镜联合手术结合透明质酸钠防治输卵管疏通术后再阻塞23例(宫、腹 透明质酸钠组);(2)单纯宫、腹腔镜联合手术治疗输卵管性不孕30例(宫、腹腔镜联合手术组)。病例纳入标准:(1)婚后同居2年,男方生殖功能正常,未避孕而未受…     

宫-腹腔镜联合输卵管复通术再通输卵管的效果评价

目的：评价宫-腹腔镜联合输卵管复通术的术后输卵管复通率及输卵管不同部位的复通率。方法：对2008年1月—2009年12月880例不孕症患者共1 760条输卵管进行宫-腹腔镜联合输卵管复通术,观察其术后的输卵管复通率。结果：宫-腹腔镜联合输卵管复通术的复通率为74.5%。其中,间质部为65.8%,峡部为56.5%,壶腹部为36.7%,伞端为86.0%。术后随访2年自然妊娠率39.6%。结论：输卵管伞端复通率最高,间质部次之,壶腹部复通率最低。     

超声输卵管盆腔显影术67例临床报告

目的　探讨超声输卵管盆腔显影术在诊治不孕症的临床意义。方法　回顾分析 2 0 0 2年 6月至 2 0 0 3年 6月广东省佛山市顺德区第一人民医院 6 7例不孕症患者超声输卵管盆腔显影术并随后行腹腔镜探查术的临床资料。结果　超声输卵管盆腔显影术和腹腔镜探查术 ,子宫、卵巢和输卵管检查结果差异无显著性意义 (P >0 0 5 )。结论　超声输卵管盆腔显影术可初步了解输卵管通畅性、形态及与周围组织、卵巢有无粘连。有助于不孕症患者明确腹腔镜探查指征。     

Combined diagnostic approach of laparoscopy and hysteroscopy in the evaluation of female infertility: results of 612 patients

AIM: To clarify the role of a combined diagnostic approach using laparoscopy and hysteroscopy in the evaluation of female infertility in developing countries. METHODS: In a prospective study, 612 consecutive infertile women underwent complete fertility evaluation at a tertiary university infertility clinic: 300 complained of primary infertility, 221 of secondary infertility, and 91 were requesting reversal of a previous tubal ligation. All the patients were examined by simultaneous combined laparoscopy and hysteroscopy as a part of their routine infertility evaluation. Focused hysteroscopic evaluation of the region of utero-tubal junction was attempted. RESULTS: Laparoscopy was successful in 608 and hysteroscopy in 597 patients. The most frequent pathologies detected hysteroscopically in the infertile group were adhesive in nature and believed to be post-traumatic and/or post-phlogistic. The number of intrauterine abnormalities found by hysteroscopy was significantly greater than by hysterosalpingography. The rate of diagnosis of significant lesions by laparoscopy of 64.3% rose to 76.6% when the hysteroscopic findings were included. A significant number of women with secondary infertility had abnormal hysteroscopic findings when compared to either women with primary infertility or those requesting sterilization reversal. Hysteroscopic evaluation of the region of utero-tubal junction revealed significant lesions believed to have caused infertility in comparison with those requesting sterilization reversal. CONCLUSION: The combined diagnostic approach of laparoscopy and hysteroscopy is recommended in the evaluation of female infertility in communities where the risk of pelvic infections is great.     

腹腔镜联合宫腔镜诊治输卵管性不孕52例分析

目的探讨应用宫、腹腔镜对输卵管性不孕的诊断价值及治疗效果.方法对52例经子宫输卵管碘油造影(HSG)诊断为输卵管性不孕的患者,单用腹腔镜下子宫导管内加压注入美蓝液检查证实双侧输卵管通畅者8例,一侧通畅者4例,双侧因各不同部位梗阻而不通者40例.对双侧及一侧不通的44例患者,根据不同部位病变进行治疗,如盆腔粘连松解,伞端扩张、造口及宫腔镜下输卵管间质部插管加压通液,开腹显微外科输卵管吻合、宫角植入等.结果52例输卵管性不孕患者中,双侧榆卵管通畅40例(77%),单侧通畅10例(19%),完全不通2例(3.9%).结论应用宫、腹腔镜联合检查、治疗输卵管性不孕,可避免单独使用宫腔镜、腹腔镜或开腹整形的局限性,提高诊断的准确性及治疗效果.     

Comparison of diagnostic accuracy of laparoscopy, hysteroscopy, and hysterosalpingography in evaluation of female infertility

The diagnostic accuracy and therapeutic value of hysterosalpingography (HSG), laparoscopy, and hysteroscopy were evaluated in 77 women who underwent these procedures as part of their infertility evaluation. HSG revealed in 32 women (42%) evidence of tubal or peritoneal disease, and 16 other women (21%) had radiographic evidence of intrauterine abnormalities. These findings were confirmed by laparoscopy in 84% of patients and by hysteroscopy in 69%, giving false-positive rates of 16% and 31% for HSG. HSG had a false-negative rate of 13% for tubal or peritoneal disease as subsequently uncovered by laparoscopy, and 1.3% for intrauterine lesions as revealed by hysteroscopy. The data suggest that while laparoscopy is of value in detecting previously unsuspected tubal disease, hysteroscopy adds little information in the management of the infertile patient. For optimum evaluation, a combined approach using all three procedures is recommended, especially in patients with a history of uterotubal and peritoneal lesions.     

Hysterosalpingography, laparoscopy and hysteroscopy in infertility. A comparative study.

The accuracy and significance of hysterosalpingography (HSG) during an infertility evaluation were assessed by comparing the radiologic findings on HSG to the operative findings during laparoscopy and hysteroscopy. One hundred ninety-three patients underwent a complete infertility evaluation at our center. HSG was performed during the proliferative phase and was followed by laparoscopy and hysteroscopy, when indicated, during the same or next cycle. False-positive findings on HSG were noted in 5.1% of the patients. In 21%, adnexal adhesions and pelvic endometriosis were identified during surgery in spite of normal HSG. HSG is as accurate as laparoscopy in the diagnosis of tubal disease. However, laparoscopy excels HSG in the diagnosis of pelvic pathology. HSG should remain an integral part of the female infertility investigation and must be performed before laparoscopy and hysteroscopy.     

Combined laparoscopy and hysteroscopy in the investigation of the ovulatory infertile female

A previous study had demonstrated the superiority of hysteroscopy over hysterosalpingography for the detection of intrauterine lesions in infertile patients. One hundred and sixty-nine patients were examined by a combined laparoscopic and hysteroscopic technique as the means of detecting tubal, peritubal, peritoneal, or intrauterine causes of infertility. Laparoscopy was successful in 168 and hysteroscopy in 162. The rate of diagnosis by laparoscopy of 49.4% was increased to 66% when the hysteroscopic findings were included. Only one serious complication was recorded, the inadvertent visualization of an intrauterine pregnancy. Arguments are advanced for the replacement of hysterosalpingography with combined laparoscopy and hysteroscopy as the primary means of investigating the ovulatory infertile female.     

输卵管阻塞性不孕症宫、腹腔镜术后治疗方法的探讨

目的:探讨输卵管阻塞性不孕症宫、腹腔镜术后阻止再次粘连和阻塞的诊疗方法。方法:将宫、腹腔镜术后至少一侧输卵管通畅的不孕症患者随机分为治疗组和对照组,治疗组和对照组分别术后第1次月经干净后3~7 d应用欣可聍或注射体积分数20%甲硝唑氯化钠注射液进行彩色B超监测下宫腔镜输卵管插管通液;观察术后1年的妊娠情况,术后1年未孕者,于月经干净后3~7 d行子宫输卵管碘佛醇造影检查,了解输卵管通畅度。结果:术后1年治疗组妊娠率(68.75%)高于对照组(51.25%),差异有统计学意义(χ2=5.104,P=0.024);异位妊娠差异无统计学意义(P0.05);未孕者治疗组双侧输卵管通畅率(40.9%)高于对照组(14.2%),差异有统计学意义(χ2=5.168,P=0.023)。结论:输卵管阻塞性不孕症宫、腹腔镜术后第1次月经干净后3~7 d用欣可聍注射液进行彩色B超监测下宫腔镜输卵管插管通液,可以降低盆腔的再次粘连,维持输卵管的通畅,提高受孕率,值得临床推广应用。     

880例不孕妇女宫-腹腔镜联合手术的病因分析

目的:探讨应用宫-腹腔镜联合手术的诊断技术对女性因素不孕病因的诊断价值。方法:对880例不孕症患者经宫-腹腔镜联合手术,诊断其盆腔疾病、宫腔疾病和不孕的可能原因。结果:在880例不孕症患者中,676例患有盆腔粘连,占76.8%;双侧输卵管阻塞者503例,占57.1%;子宫因素者112例,占12.7%;宫腔病变者107例,占12.2%;卵巢因素者103例,占11.7%;生殖器畸形者69例,占7.9%。其中原发不孕者中痛经、多囊卵巢的患者多于继发不孕,而继发不孕者中有盆腔炎症和盆腹腔手术史的比例较多。结论:女性不孕的首要暴露因素(危险因素)是盆腔及生殖道感染性疾病,输卵管阻塞是导致不孕的重要因素之一。应用宫-腹腔镜联合手术对女性不孕症的病因诊断有重要价值并能对盆腔粘连、输卵管疾病在诊断的同时进行治疗。     

ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients

This study investigated the use of hysteroscopic Essure device placement for the treatment of hydrosalpinx-related infertility in patients with laparoscopic contraindications and compared their pregnancy outcomes following assisted conception treatment with those of patients having had laparoscopic tubal ligation. A total of 102 infertile patients were diagnosed with unilateral or bilateral hydrosalpinges: 26 patients had laparoscopic contraindications and were treated hysterscopically and 76 patients were treated laparoscopically. In total, 66 intracytoplasmic sperm injection (ICSI) and 39 frozen embryo transfer (FET) procedures were performed. In the hysteroscopy group, 13 ICSI and eight FET in 16 patients resulted in 10 pregnancies (pregnancy rates 47.6% per transfer and 62.5% per patient), and in the laparoscopy group, 53 ICSI and 31 FET embryo transfers in 54 patients resulted in 36 pregnancies (pregnancy rates 42.9% per transfer and 66.7% per patient). Live birth rates per assisted reproduction procedure were 23.8% (5/21) in the hysteroscopy group and 32.1% (27/84) for the laparoscopy group. The hysteroscopic placement of Essure devices to isolate hydrosalpinx prior to assisted conception treatment produced pregnancy outcomes comparable to those produced following laparoscopic tubal ligation. The live birth rates indicate that a larger, more comparative, prospectively randomized study is required.Infertile patients with tubal disease require surgical treatment before they can continue with fertility treatment. There are two main surgical methods that can be used, hysteroscopic and laparoscopic, the latter being the standard surgical method. However, some patients have disease that makes the use of laparoscopy inappropriate. For these patients the placement of Essure® devices by hysteroscopic surgery maybe the most suitable treatment method. One hundred and two patients were diagnosed with unilateral or bilateral hydrosalpinges – tubal disease. Twenty six patients had to have hysterscopic surgery and 76 patients had laparoscopic surgery. After their tubal surgery some patients continued to have fertility treatment, 66 ICSI and 39 frozen embryo transfers (FET) were performed. Thirteen ICSI and 8 FET embryo transfers in 16 patients from the hysteroscopy group resulted in 10 pregnancies, a 47.6% per transfer and 62.5% per patient pregnancy rate. Fifty three ICSI and 31 FET embryo transfers in 54 patients from the laparoscopic group resulted in 36 pregnancies, a 42.9% per transfer and 66.7% per patient rate. Live birth rates per ART procedure were 23.8% (5/21) in the hysteroscopic group compared with 32.1% (27/84) for the laparoscopic group. The hysteroscopic placement of Essure® devices for tubal disease prior to fertility treatments resulted in pregnancy outcomes that were comparable to the outcomes obtained following laparoscopic surgery.